Human Insulin Delivery System Market Insights, Global Outlook and Forecast 2022-2028
Human Insulin Delivery System Market Insights, Global Outlook and Forecast 2022-2028
Human Insulin Delivery System Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Human insulin delivery system is an alternative to multiple daily injections of insulin by insulin syringes or an insulin pen and allows for flexible insulin therapy when used in conjunction with blood glucose monitoring and carbohydrate counting for human being.
The latest research study released by Market IntelliX evaluates market size and forecasts of Human Insulin Delivery System in global, including the following market information:
Global Human Insulin Delivery System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Insulin Delivery System Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Insulin Delivery System companies in 2021 (%)
The global Human Insulin Delivery System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Automatic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Insulin Delivery System include BD, Novo Nordisk, Medtronic, Sanofi, ELI Lilly and Company, Ypsomed Holding, Animas Corporation, Tandem Diabetes Care and Insulet Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Human Insulin Delivery System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Human Insulin Delivery System Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Insulin Delivery System Market Segment Percentages, by Type, 2021 (%)
Automatic
Manual
Global Human Insulin Delivery System Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Insulin Delivery System Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Homecare
Global Human Insulin Delivery System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Insulin Delivery System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Insulin Delivery System revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Insulin Delivery System revenues share in global market, 2021 (%)
Key companies Human Insulin Delivery System sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Insulin Delivery System sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
BD
Novo Nordisk
Medtronic
Sanofi
ELI Lilly and Company
Ypsomed Holding
Animas Corporation
Tandem Diabetes Care
Insulet Corporation
Biocon
Roche
Johnson & Johnson
Microport
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Human Insulin Delivery System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Insulin Delivery System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Insulin Delivery System Overall Market Size
2.1 Global Human Insulin Delivery System Market Size: 2021 VS 2028
2.2 Global Human Insulin Delivery System Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Insulin Delivery System Sales: 2017-2028
3 Company Landscape
3.1 Top Human Insulin Delivery System Players in Global Market
3.2 Top Global Human Insulin Delivery System Companies Ranked by Revenue
3.3 Global Human Insulin Delivery System Revenue by Companies
3.4 Global Human Insulin Delivery System Sales by Companies
3.5 Global Human Insulin Delivery System Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Insulin Delivery System Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Insulin Delivery System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Insulin Delivery System Players in Global Market
3.8.1 List of Global Tier 1 Human Insulin Delivery System Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Insulin Delivery System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Insulin Delivery System Market Size Markets, 2021 & 2028
4.1.2 Automatic
4.1.3 Manual
4.2 By Type - Global Human Insulin Delivery System Revenue & Forecasts
4.2.1 By Type - Global Human Insulin Delivery System Revenue, 2017-2022
4.2.2 By Type - Global Human Insulin Delivery System Revenue, 2023-2028
4.2.3 By Type - Global Human Insulin Delivery System Revenue Market Share, 2017-2028
4.3 By Type - Global Human Insulin Delivery System Sales & Forecasts
4.3.1 By Type - Global Human Insulin Delivery System Sales, 2017-2022
4.3.2 By Type - Global Human Insulin Delivery System Sales, 2023-2028
4.3.3 By Type - Global Human Insulin Delivery System Sales Market Share, 2017-2028
4.4 By Type - Global Human Insulin Delivery System Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Human Insulin Delivery System Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Homecare
5.2 By Application - Global Human Insulin Delivery System Revenue & Forecasts
5.2.1 By Application - Global Human Insulin Delivery System Revenue, 2017-2022
5.2.2 By Application - Global Human Insulin Delivery System Revenue, 2023-2028
5.2.3 By Application - Global Human Insulin Delivery System Revenue Market Share, 2017-2028
5.3 By Application - Global Human Insulin Delivery System Sales & Forecasts
5.3.1 By Application - Global Human Insulin Delivery System Sales, 2017-2022
5.3.2 By Application - Global Human Insulin Delivery System Sales, 2023-2028
5.3.3 By Application - Global Human Insulin Delivery System Sales Market Share, 2017-2028
5.4 By Application - Global Human Insulin Delivery System Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Human Insulin Delivery System Market Size, 2021 & 2028
6.2 By Region - Global Human Insulin Delivery System Revenue & Forecasts
6.2.1 By Region - Global Human Insulin Delivery System Revenue, 2017-2022
6.2.2 By Region - Global Human Insulin Delivery System Revenue, 2023-2028
6.2.3 By Region - Global Human Insulin Delivery System Revenue Market Share, 2017-2028
6.3 By Region - Global Human Insulin Delivery System Sales & Forecasts
6.3.1 By Region - Global Human Insulin Delivery System Sales, 2017-2022
6.3.2 By Region - Global Human Insulin Delivery System Sales, 2023-2028
6.3.3 By Region - Global Human Insulin Delivery System Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Human Insulin Delivery System Revenue, 2017-2028
6.4.2 By Country - North America Human Insulin Delivery System Sales, 2017-2028
6.4.3 US Human Insulin Delivery System Market Size, 2017-2028
6.4.4 Canada Human Insulin Delivery System Market Size, 2017-2028
6.4.5 Mexico Human Insulin Delivery System Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Human Insulin Delivery System Revenue, 2017-2028
6.5.2 By Country - Europe Human Insulin Delivery System Sales, 2017-2028
6.5.3 Germany Human Insulin Delivery System Market Size, 2017-2028
6.5.4 France Human Insulin Delivery System Market Size, 2017-2028
6.5.5 U.K. Human Insulin Delivery System Market Size, 2017-2028
6.5.6 Italy Human Insulin Delivery System Market Size, 2017-2028
6.5.7 Russia Human Insulin Delivery System Market Size, 2017-2028
6.5.8 Nordic Countries Human Insulin Delivery System Market Size, 2017-2028
6.5.9 Benelux Human Insulin Delivery System Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Human Insulin Delivery System Revenue, 2017-2028
6.6.2 By Region - Asia Human Insulin Delivery System Sales, 2017-2028
6.6.3 China Human Insulin Delivery System Market Size, 2017-2028
6.6.4 Japan Human Insulin Delivery System Market Size, 2017-2028
6.6.5 South Korea Human Insulin Delivery System Market Size, 2017-2028
6.6.6 Southeast Asia Human Insulin Delivery System Market Size, 2017-2028
6.6.7 India Human Insulin Delivery System Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Human Insulin Delivery System Revenue, 2017-2028
6.7.2 By Country - South America Human Insulin Delivery System Sales, 2017-2028
6.7.3 Brazil Human Insulin Delivery System Market Size, 2017-2028
6.7.4 Argentina Human Insulin Delivery System Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Insulin Delivery System Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Human Insulin Delivery System Sales, 2017-2028
6.8.3 Turkey Human Insulin Delivery System Market Size, 2017-2028
6.8.4 Israel Human Insulin Delivery System Market Size, 2017-2028
6.8.5 Saudi Arabia Human Insulin Delivery System Market Size, 2017-2028
6.8.6 UAE Human Insulin Delivery System Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 BD
7.1.1 BD Corporate Summary
7.1.2 BD Business Overview
7.1.3 BD Human Insulin Delivery System Major Product Offerings
7.1.4 BD Human Insulin Delivery System Sales and Revenue in Global (2017-2022)
7.1.5 BD Key News
7.2 Novo Nordisk
7.2.1 Novo Nordisk Corporate Summary
7.2.2 Novo Nordisk Business Overview
7.2.3 Novo Nordisk Human Insulin Delivery System Major Product Offerings
7.2.4 Novo Nordisk Human Insulin Delivery System Sales and Revenue in Global (2017-2022)
7.2.5 Novo Nordisk Key News
7.3 Medtronic
7.3.1 Medtronic Corporate Summary
7.3.2 Medtronic Business Overview
7.3.3 Medtronic Human Insulin Delivery System Major Product Offerings
7.3.4 Medtronic Human Insulin Delivery System Sales and Revenue in Global (2017-2022)
7.3.5 Medtronic Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Human Insulin Delivery System Major Product Offerings
7.4.4 Sanofi Human Insulin Delivery System Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 ELI Lilly and Company
7.5.1 ELI Lilly and Company Corporate Summary
7.5.2 ELI Lilly and Company Business Overview
7.5.3 ELI Lilly and Company Human Insulin Delivery System Major Product Offerings
7.5.4 ELI Lilly and Company Human Insulin Delivery System Sales and Revenue in Global (2017-2022)
7.5.5 ELI Lilly and Company Key News
7.6 Ypsomed Holding
7.6.1 Ypsomed Holding Corporate Summary
7.6.2 Ypsomed Holding Business Overview
7.6.3 Ypsomed Holding Human Insulin Delivery System Major Product Offerings
7.6.4 Ypsomed Holding Human Insulin Delivery System Sales and Revenue in Global (2017-2022)
7.6.5 Ypsomed Holding Key News
7.7 Animas Corporation
7.7.1 Animas Corporation Corporate Summary
7.7.2 Animas Corporation Business Overview
7.7.3 Animas Corporation Human Insulin Delivery System Major Product Offerings
7.7.4 Animas Corporation Human Insulin Delivery System Sales and Revenue in Global (2017-2022)
7.7.5 Animas Corporation Key News
7.8 Tandem Diabetes Care
7.8.1 Tandem Diabetes Care Corporate Summary
7.8.2 Tandem Diabetes Care Business Overview
7.8.3 Tandem Diabetes Care Human Insulin Delivery System Major Product Offerings
7.8.4 Tandem Diabetes Care Human Insulin Delivery System Sales and Revenue in Global (2017-2022)
7.8.5 Tandem Diabetes Care Key News
7.9 Insulet Corporation
7.9.1 Insulet Corporation Corporate Summary
7.9.2 Insulet Corporation Business Overview
7.9.3 Insulet Corporation Human Insulin Delivery System Major Product Offerings
7.9.4 Insulet Corporation Human Insulin Delivery System Sales and Revenue in Global (2017-2022)
7.9.5 Insulet Corporation Key News
7.10 Biocon
7.10.1 Biocon Corporate Summary
7.10.2 Biocon Business Overview
7.10.3 Biocon Human Insulin Delivery System Major Product Offerings
7.10.4 Biocon Human Insulin Delivery System Sales and Revenue in Global (2017-2022)
7.10.5 Biocon Key News
7.11 Roche
7.11.1 Roche Corporate Summary
7.11.2 Roche Human Insulin Delivery System Business Overview
7.11.3 Roche Human Insulin Delivery System Major Product Offerings
7.11.4 Roche Human Insulin Delivery System Sales and Revenue in Global (2017-2022)
7.11.5 Roche Key News
7.12 Johnson & Johnson
7.12.1 Johnson & Johnson Corporate Summary
7.12.2 Johnson & Johnson Human Insulin Delivery System Business Overview
7.12.3 Johnson & Johnson Human Insulin Delivery System Major Product Offerings
7.12.4 Johnson & Johnson Human Insulin Delivery System Sales and Revenue in Global (2017-2022)
7.12.5 Johnson & Johnson Key News
7.13 Microport
7.13.1 Microport Corporate Summary
7.13.2 Microport Human Insulin Delivery System Business Overview
7.13.3 Microport Human Insulin Delivery System Major Product Offerings
7.13.4 Microport Human Insulin Delivery System Sales and Revenue in Global (2017-2022)
7.13.5 Microport Key News
8 Global Human Insulin Delivery System Production Capacity, Analysis
8.1 Global Human Insulin Delivery System Production Capacity, 2017-2028
8.2 Human Insulin Delivery System Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Insulin Delivery System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Insulin Delivery System Supply Chain Analysis
10.1 Human Insulin Delivery System Industry Value Chain
10.2 Human Insulin Delivery System Upstream Market
10.3 Human Insulin Delivery System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Insulin Delivery System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Human Insulin Delivery System Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|